The Personalized Treatment of Breast Cancer
Presented by Merry L Tetef, MD
About the Lecture
One in eight women will be diagnosed with breast cancer during their lifetime. Early screening and advanced treatments have paved the road to survivorship. It is now known that breast cancer encompasses a number of different subtypes, and there is not one best treatment path for all women. Rather, breast cancer treatments vary depending on the specific nature of each woman’s cancer. Personalized treatments are being used in surgical oncology, radiation oncology and medical oncology to tailor the appropriate management to the molecular and clinical features of each women’s specific breast cancer. Rapid scientific developments are quickly leading to more targeted therapies, aimed at defined sub-types of breast cancer in order to give the most effective therapy to each woman. Clinical research trials also are progressing at a rapid pace, to develop new treatments in this exciting, growing field. Dr Tetef will review current trends in the way the current treatments for breast cancer are focused on specific features of the cancer, and will discuss what is next, looking ahead to future clinical research.
About the Speaker
Merry L. Tetef, MD, is Associate Clinical Professor in the Department of Medicine, Division of Hematology/Oncology of the David Geffen School of Medicine of UCLA. At her UCLA office in Orange County, Dr. Tetef is a board-certified medical oncologist with a busy clinical practice. Through the UCLA clinical research network, she participates in numerous clinical trials, providing cutting-edge novel treatment options to her patients. With many years of clinical practice and research experience at both City of Hope and UCLA, Dr. Tetef works closely with each of her patients to jointly decide their best course of treatment.